Placeholder description for Explorna, a company focused on providing innovative solutions in the field of data analytics and business intelligence. The company leverages cutting-edge technology to help businesses make data-driven decisions and improve their operational efficiency.

Explorna

Our mission is to deliver mRNA technology innovations to revolutionize future therapies and the prevention of many diseases. We invent, develop, manufacture and apply our solutions for the benefit of pharmaceutical partners, and to improve people’s lives.

With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform, and therapies to pharmaceutical partners.  

The future of healthcare belongs to therapeutic mRNA.

Bill & Melinda Gates Foundation

ExploRNA Therapeutics

We are happy to share the final version of our team's work in collaboration with the University of Warsaw. This work is dedicated to our novel 5' mRNA cap analog. It is a mix of scientific excellence, inspiration from nature, and a drive to improve the growing industry using mRNA to create new vaccines and therapies. We'd like to thank our fantastic collaborators and team for this journey together! Enjoy and feel free to comment!  https://lnkd.in/dZ_mjH5P #mrna #mrnavaccines #mrnatherapeutics Jacek Jemielity Joanna Kowalska Dominika Nowis Edyta Trepkowska Marek Baranowski Hanna Kędzierska Diana Papiernik Agnieszka Popielec Piotr Sklepkiewicz Marta Skłucka Tomasz Śpiewla Diana Toczydłowska-Socha Paweł Turowski

Metric
Company Name	Explorna
Symbol
MSH ID	COM:EXPLORNA
Market	PRIVATE
Sector	Technology
Industry	Technology
Country	PL
Stage
Employee Count	16
Website	explorna.com
LinkedIn	explorna-therapeutics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:EXPLORNA

Explorna

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue